Market research
EKSO Ekso Bionics Holdings Inc
NASDAQ USD Healthcare
Latest close
As of 07 Jun 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 42M
- P/E ratio
- Not available
- Analyst target
- 9.5
- Dividend yield
- Not available
- Beta
- 0.78
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- Not available
- Market cap
- 42M
- P/E ratio
- Not available
- Analyst target
- 9.5
- Dividend yield
- Not available
- Beta
- 0.78
About
About Ekso Bionics Holdings Inc
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
Research context
Ekso Bionics Holdings Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the EKSO discussion.
5 years, 6 months ago
Ekso Bionics Holdings, Inc is currently in a long term downtrend where the price is trading 17.3% below its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.1.
Ekso Bionics Holdings, Inc's total revenue sank by 39.4% to $2M since the same quarter in the previous year.
Its net income has dropped by 46.1% to $-4M since the same quarter in the previous year.
Finally, its free cash flow fell by 11.9% to $-2M since the same quarter in the previous year.
Based on the above factors, Ekso Bionics Holdings, Inc gets an overall score of 1/5.